tiprankstipranks
Centene (CH:QEN)
:QEN
Switzerland Market
QEN
Centene
RESEARCH TOOLSreports

Centene (QEN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

QEN Analyst Ratings

Moderate Buy
15Ratings
Moderate Buy
6 Buy
9 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Centene
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QEN Stock 12 Month Forecast

Average Price Target

―
Based on 15 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is CHF57.93 with a high forecast of CHF63.93 and a low forecast of CHF51.94. The average price target represents a ― change from the last price of ―.
eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==
Highest Price TargetCHF63.93Average Price TargetCHF57.93Lowest Price TargetCHF51.94
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:QEN
John Stansel
J.P. Morgan
J.P. Morgan
CHF53.54
Hold
―
Assigned
08/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioNTech SE (NASDAQ: BNTX) and Centene (NYSE: CNC)
Barclays Analyst forecast on CH:QEN
Andrew Mok CFA
Barclays
Barclays
CHF63.93
Buy
―
Reiterated
08/18/26
Barclays Sticks to Its Buy Rating for Centene (CNC)
Bernstein Analyst forecast on CH:QEN
Lance Wilkes
Bernstein
Bernstein
CHF63.13
Buy
―
Reiterated
08/14/26
Analysts Offer Insights on Healthcare Companies: Cellectar Biosciences (NASDAQ: CLRB), NeuroOne Medical Technologies (NASDAQ: NMTC) and Centene (NYSE: CNC)
Argus Research Analyst forecast on CH:QEN
John Staszak
Argus Research
Argus Research
CHF63.93
Buy
―
Upgraded
08/10/26
Centene upgraded to Buy from Hold at ArgusCentene upgraded to Buy from Hold at Argus
TD Cowen Analyst forecast on CH:QEN
Ryan Langston
TD Cowen
TD Cowen
CHF51.94
Hold
―
Assigned
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)
Morgan Stanley Analyst forecast on CH:QEN
Erin Wright
Morgan Stanley
Morgan Stanley
CHF45.55→CHF52.74
Hold
―
Reiterated
07/29/26
Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns
Truist Financial Analyst forecast on CH:QEN
David S Macdonald
Truist Financial
Truist Financial
CHF62.33→CHF63.93
Buy
―
Reiterated
07/29/26
Truist Financial Keeps Their Buy Rating on Centene (CNC)
UBS Analyst forecast on CH:QEN
A.J. Rice
UBS
UBS
CHF48.74→CHF55.93
Hold
―
Reiterated
07/29/26
Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS
Robert W. Baird Analyst forecast on CH:QEN
Michael Ha
Robert W. Baird
Robert W. Baird
CHF36.76→CHF52.74
Hold
―
Reiterated
07/29/26
Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird
RBC Capital Analyst forecast on CH:QEN
Ben Hendrix
RBC Capital
RBC Capital
CHF56.73
Hold
―
Reiterated
07/28/26
RBC Capital Reaffirms Their Hold Rating on Centene (CNC)
Cantor Fitzgerald Analyst forecast on CH:QEN
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
CHF59.93
Buy
―
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
Guggenheim Analyst forecast on CH:QEN
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
07/28/26
Guggenheim Sticks to Its Hold Rating for Centene (CNC)
Bank of America Securities Analyst forecast on CH:QEN
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF62.33
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on CH:QEN
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF50.34→CHF55.14
Hold
―
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Centene (CNC)
Wells Fargo Analyst forecast on CH:QEN
Stephen Baxter
Wells Fargo
Wells Fargo
CHF44.75→CHF55.14
Hold
―
Reiterated
07/13/26
Centene price target raised to $69 from $56 at Wells FargoCentene price target raised to $69 from $56 at Wells Fargo
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:QEN
John Stansel
J.P. Morgan
J.P. Morgan
CHF53.54
Hold
―
Assigned
08/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioNTech SE (NASDAQ: BNTX) and Centene (NYSE: CNC)
Barclays Analyst forecast on CH:QEN
Andrew Mok CFA
Barclays
Barclays
CHF63.93
Buy
―
Reiterated
08/18/26
Barclays Sticks to Its Buy Rating for Centene (CNC)
Bernstein Analyst forecast on CH:QEN
Lance Wilkes
Bernstein
Bernstein
CHF63.13
Buy
―
Reiterated
08/14/26
Analysts Offer Insights on Healthcare Companies: Cellectar Biosciences (NASDAQ: CLRB), NeuroOne Medical Technologies (NASDAQ: NMTC) and Centene (NYSE: CNC)
Argus Research Analyst forecast on CH:QEN
John Staszak
Argus Research
Argus Research
CHF63.93
Buy
―
Upgraded
08/10/26
Centene upgraded to Buy from Hold at ArgusCentene upgraded to Buy from Hold at Argus
TD Cowen Analyst forecast on CH:QEN
Ryan Langston
TD Cowen
TD Cowen
CHF51.94
Hold
―
Assigned
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)
Morgan Stanley Analyst forecast on CH:QEN
Erin Wright
Morgan Stanley
Morgan Stanley
CHF45.55→CHF52.74
Hold
―
Reiterated
07/29/26
Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns
Truist Financial Analyst forecast on CH:QEN
David S Macdonald
Truist Financial
Truist Financial
CHF62.33→CHF63.93
Buy
―
Reiterated
07/29/26
Truist Financial Keeps Their Buy Rating on Centene (CNC)
UBS Analyst forecast on CH:QEN
A.J. Rice
UBS
UBS
CHF48.74→CHF55.93
Hold
―
Reiterated
07/29/26
Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS
Robert W. Baird Analyst forecast on CH:QEN
Michael Ha
Robert W. Baird
Robert W. Baird
CHF36.76→CHF52.74
Hold
―
Reiterated
07/29/26
Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird
RBC Capital Analyst forecast on CH:QEN
Ben Hendrix
RBC Capital
RBC Capital
CHF56.73
Hold
―
Reiterated
07/28/26
RBC Capital Reaffirms Their Hold Rating on Centene (CNC)
Cantor Fitzgerald Analyst forecast on CH:QEN
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
CHF59.93
Buy
―
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
Guggenheim Analyst forecast on CH:QEN
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
07/28/26
Guggenheim Sticks to Its Hold Rating for Centene (CNC)
Bank of America Securities Analyst forecast on CH:QEN
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF62.33
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on CH:QEN
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF50.34→CHF55.14
Hold
―
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Centene (CNC)
Wells Fargo Analyst forecast on CH:QEN
Stephen Baxter
Wells Fargo
Wells Fargo
CHF44.75→CHF55.14
Hold
―
Reiterated
07/13/26
Centene price target raised to $69 from $56 at Wells FargoCentene price target raised to $69 from $56 at Wells Fargo
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

3 Months
Lance WilkesBernstein
Success Rate
16/23 ratings generated profit
70%
Average Return
+9.57%
Copying Lance Wilkes's trades and holding each position for 3 Months would result in 69.57% of your transactions generating a profit, with an average return of +9.57% per trade.
1 Year
Kevin FischbeckBank of America Securities
Success Rate
16/23 ratings generated profit
70%
Average Return
+0.95%
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 69.57% of your transactions generating a profit, with an average return of +0.95% per trade.
2 Years
Lance WilkesBernstein
Success Rate
17/23 ratings generated profit
74%
Average Return
+33.24%
Copying Lance Wilkes's trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +33.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QEN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
2
0
0
0
Buy
13
12
17
16
16
Hold
16
14
15
20
17
Sell
5
4
3
0
0
Strong Sell
0
0
0
0
0
total
36
32
35
36
33
In the current month, QEN has received 16 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. QEN average Analyst price target in the past 3 months is 57.93.
Each month's total comprises the sum of three months' worth of ratings.

QEN Financial Forecast

QEN Earnings Forecast

Next quarter’s earnings estimate for QEN is CHF0.08 with a range of CHF0.00 to CHF0.26. The previous quarter’s EPS was CHF2.01. QEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for QEN is CHF0.08 with a range of CHF0.00 to CHF0.26. The previous quarter’s EPS was CHF2.01. QEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QEN has Performed in-line its overall industry.

QEN Sales Forecast

Next quarter’s sales forecast for QEN is CHF37.65B with a range of CHF36.46B to CHF39.29B. The previous quarter’s sales results were CHF42.81B. QEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QEN has Performed in-line its overall industry.
Next quarter’s sales forecast for QEN is CHF37.65B with a range of CHF36.46B to CHF39.29B. The previous quarter’s sales results were CHF42.81B. QEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QEN has Performed in-line its overall industry.

QEN Stock Forecast FAQ

What is CH:QEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Centene’s 12-month average price target is 57.93.
    What is CH:QEN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:QEN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Centene a Buy, Sell or Hold?
        Centene has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 9 hold ratings and 0 sell ratings.
          What is Centene’s share price target?
          The average share price target for Centene is 57.93. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF63.93 ,and the lowest forecast is CHF51.94. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Centene?
            Centene’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
              How can I buy shares of Centene?
              To buy shares of CH:QEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.